New Hope for Patients with Hepatitis C

FROM HOPE TO cures NEW HOPE НОРЕ FOR PATIENTS WITH HEPATITIS C THE BURDEN OF HEPATITIS C Hepatitis C affects 5 times as many Americans as the AIDS virus and places a huge burden on the backs of both U.S. tax-payers and the economy 12 THOUSAND 150+ MILLION 20 THOUSAND Estimated yearly deaths from hepatitis C related illness New hepatitis C transmissions each year Afflicted with hepatitis C worldwide FINANCIAL COSTS $30 BILLION $85 BILLION Expected annual medical costs for Annual medical costs for patients with hepatitis C patients by 2018 DISEASE PROGRESSION Without treatment, the disease will often progress and require more serious care that could have been prevented 70% 20% Patients with Patients with Patients with hepatitis C who may develop chronic liver disease hepatitis C who may develop cirrhosis hepatitis C who may develop liver cancer U.S. patients waiting for a liver transplant, mainly due to hepatitis C = Thousand People COST OF TREATMENTS FROM HOPE TO cures Average annual cost of early hepatitis C $24,000 treatment Average annual cost for end-stage liver disease treatment $60,000 Average annual cost for liver cancer $112,000 treatment Average annual cost of a liver transplant $500,000 THE VALUE OF TREATMENT New and forthcoming medicines can halt disease progression and even provide a cure. CURE RATES DOUBLED With new innovative medicines cure rates have almost doubled 90% 50% 2013-now 2000-2011 TREATMENT TIME Innovative medicines have cut average treatment time by 400% 12WEEKS 48M WEEKS Current Average Former Average HOPE FOR THE FUTURE New and forthcoming medicines are bringing new hope to patients with hepatitis C. Learn more by visiting www.FromHopetoCures.org FROM HOPE TO cures 2018 2014